GenOMICC [COVID-19] [UPH]
Research type
Research Study
Full title
Genetics of susceptibility and mortality in critical care (GenOMICC)
IRAS ID
189676
Contact name
Chris Coner
Contact email
Eudract number
n/a
Duration of Study in the UK
13 years, 11 months, 31 days
Research summary
Our genes determine how susceptible (likely to get) we are to life-threatening infection, and when a patient is already sick, different genetic factors determine how likely they are to survive. The GenOMICC (Genetics of Susceptibility and Mortality in Critical Care) study will identify the specific genes that cause some people to be more likely to get particular infections and more likely to end up being severely ill. Identifying these genes may help us to use existing treatments better, and to design new treatments to help people survive serious illness. To do this, we will compare cells and DNA (the genetic code that determines all of a person’s characteristics found in the cell nucleus) from carefully selected patients with those from healthy people. The study, which started in 2016, will include COVID-19 patients. [COVID-19 amendment - 23/03/2020]
REC name
Scotland A: Adults with Incapacity only
REC reference
15/SS/0180
Date of REC Opinion
29 Jan 2016
REC opinion
Further Information Favourable Opinion